Sundrug Co Ltd

Common Name
Sundrug
Country
Japan
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
7,145
Ticker
9989
Exchange
TOKYO STOCK EXCHANGE
Description
Sundrug Co., Ltd. is a prominent player in Japan's pharmaceutical and retail industry, operating a widespread network of drugstores and dispensing pharmacies. The company primarily focuses on providin...

Sundrug's GHG Emissions Data Preview

In 2024, Sundrug completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Sundrug has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Sundrug’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sundrug’s data sources below and access millions more through our Disclosure Search.

a. Sundrug's Integrated Report 2025
a. Sundrug's Integrated Report 2025
b. Sundrug's Integrated Report 2024
b. Sundrug's Integrated Report 2024

Insights into Sundrug's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Sundrug amounted to 231,823 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Sundrug increased by 27.33%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b

Sundrug's Scope 1 Emissions Over Time

2023202406.5 k13 k19.5 k26 ktCO2e-11%
  • Total Scope 1
  • Year-over-Year Change

What are Sundrug's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Sundrug were 22,197 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2023), Sundrug's Scope 1 emissions decreased by 10.91%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a b

What are Sundrug's Scope 2 emissions?

In 2024, Sundrug reported Scope 2 greenhouse gas (GHG) emissions of 209,626 tCO₂e without specifying the calculation method. a

Has Sundrug reduced its Scope 2 emissions over time?

Since 2018, Sundrug's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 29.85%, reflecting a rising long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2023), Sundrug's Scope 2 emissions (Unspecified Calculation Method) rose by 33.4% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a b

What methodology does Sundrug use for Scope 2 reporting?

In 2024, Sundrug reported its Scope 2 emissions using an unspecified methodology. a

Sundrug's Scope 2 Emissions Over Time

2018201920202021202220232024055 k110 k165 k220 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Sundrug's Value Chain Emissions

In 2024, Sundrug reported 2,596,463 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Sundrug includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Sundrug's Scope 3 Emissions Over Time

202320240650 k1.3 M1.95 M2.6 MtCO2e+7%
  • Total Scope 3
  • Year-over-Year Change

What are Sundrug's Scope 3 emissions?

In 2024, Sundrug reported total Scope 3 emissions of 2,596,463 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a

Compared to the previous year (2023), Sundrug's Scope 3 emissions remained relatively stable, indicating that Sundrug 's emissions have plateaued with no significant change in its value chain footprint. a b

What categories of Scope 3 emissions does Sundrug disclose?

In 2024, Sundrug reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Sundrug's Scope 3 emissions?

In 2024, the largest contributors to Sundrug's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 2,434,715 tCO₂e (93.77%)
  • Capital Goods (Cat. 2): 125,409 tCO₂e (4.83%)
  • Upstream Transportation and Distribution (Cat. 4): 17,468 tCO₂e (0.67%)

Sundrug's Scope 3 Emissions by Categories

Capital Goods(Cat. 2)(4.8%)Purchased Goods andServices (Cat. 1)(93.8%)

Insights into Sundrug’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Sundrug reported Scope 1 greenhouse gas (GHG) emissions of 22,197 tCO₂e and total revenues of USD 4,964 millions. This translates into an emissions intensity of 4.47 tCO₂e per millions USD. a

Sundrug's Scope 1 Emissions Intensity Compared to Peers

501,00020,000200,0005,000,000Scope 1 Emissions (tCO2e)505002,00010,00050,000Revenues (Millions of USD)SMAs OneYear: 2024Scope 1: 165 tCO2eRevenue: $M 631Scope 1 Intensity: 0.26 tCO2e/$MEisaiYear: 2024Scope 1: 45,666 tCO2eRevenue: $M 4,898Scope 1 Intensity: 9.32 tCO2e/$MHisamitsu PharmaceuticalYear: 2022Scope 1: 7,862 tCO2eRevenue: $M 1,040Scope 1 Intensity: 7.56 tCO2e/$MShionogi & CoYear: 2023Scope 1: 40,373 tCO2eRevenue: $M 3,203Scope 1 Intensity: 12.60 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MJCR PharmaceuticalsYear: 2022Scope 1: 3,315 tCO2eRevenue: $M 419Scope 1 Intensity: 7.92 tCO2e/$MPeptiDreamYear: 2023Scope 1: 3,156 tCO2eRevenue: $M 203Scope 1 Intensity: 15.55 tCO2e/$MSanten PharmaceuticalYear: 2024Scope 1: 17,372 tCO2eRevenue: $M 1,994Scope 1 Intensity: 8.71 tCO2e/$MH.U. Group HoldingsYear: 2022Scope 1: 13,418 tCO2eRevenue: $M 2,237Scope 1 Intensity: 6.00 tCO2e/$MSysmexYear: 2024Scope 1: 13,449 tCO2eRevenue: $M 3,047Scope 1 Intensity: 4.41 tCO2e/$MSSSugi HoldingsYear: 2023Scope 1: 1,531 tCO2eRevenue: $M 4,898Scope 1 Intensity: 0.31 tCO2e/$MOno PharmaceuticalYear: 2024Scope 1: 8,100 tCO2eRevenue: $M 3,319Scope 1 Intensity: 2.44 tCO2e/$MMatsukiyoCocokara & CoYear: 2023Scope 1: 1,764 tCO2eRevenue: $M 7,142Scope 1 Intensity: 0.25 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MSuzukenYear: 2023Scope 1: 26,491 tCO2eRevenue: $M 17,378Scope 1 Intensity: 1.52 tCO2e/$MTsuruha HoldingsYear: 2023Scope 1: 3,424 tCO2eRevenue: $M 6,940Scope 1 Intensity: 0.49 tCO2e/$MOtsuka HoldingsYear: 2021Scope 1: 1,030,000 tCO2eRevenue: $M 13,021Scope 1 Intensity: 79.10 tCO2e/$MSMSYear: 2023Scope 1: 220 tCO2eRevenue: $M 343Scope 1 Intensity: 0.64 tCO2e/$MAstellas PharmaYear: 2023Scope 1: 59,203 tCO2eRevenue: $M 11,401Scope 1 Intensity: 5.19 tCO2e/$MTsumura & CoYear: 2021Scope 1: 39,385 tCO2eRevenue: $M 1,055Scope 1 Intensity: 37.32 tCO2e/$MDaiichi SankyoYear: 2024Scope 1: 91,836 tCO2eRevenue: $M 10,576Scope 1 Intensity: 8.68 tCO2e/$MMMMedipal HoldingsYear: 2023Scope 1: 28,439 tCO2eRevenue: $M 25,225Scope 1 Intensity: 1.13 tCO2e/$MOlympusYear: 2025Scope 1: 24,120 tCO2eRevenue: $M 6,650Scope 1 Intensity: 3.63 tCO2e/$MKyowa KirinYear: 2024Scope 1: 16,133 tCO2eRevenue: $M 3,157Scope 1 Intensity: 5.11 tCO2e/$MSundrugYear: 2024Scope 1: 22,197 tCO2eRevenue: $M 4,964Scope 1 Intensity: 4.47 tCO2e/$M

How does Sundrug's GHG emissions intensity compare to its peers?

In 2024, Sundrug reported a Scope 1 emissions intensity of 4.47 tCO₂e per millions USD. Compared to the peer group median of 5.6 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Sundrug rank on GHG emissions intensity within its industry?

In 2024, Sundrug ranked 11 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Sundrug is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into Sundrug's Total Carbon Footprint

In 2024, Sundrug reported a total carbon footprint of 2,828,286 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 8.14% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a b

The largest contributor to Sundrug's total carbon footprint was Scope 3 emissions, accounting for 91.8% of the company's total carbon footprint, followed by Scope 2 emissions at 7.41%. a

Want Full Access to Sundrug's GHG Emissions Dataset?
Sign Up